Thymic and bone marrow output in individuals with 22q11.2 deletion syndrome

Pediatric Research

Volumn 77, Issue 4, 2015, Pages 579-585

  Dar, Nina ^a,b   Gothelf, Doron ^a,b   Korn, David ^a   Frisch, Amos ^b   Weizman, Abraham ^b,c   Michaelovsky, Elena ^b   Carmel, Miri ^b   Yeshayahu, Yonatan ^a,b   Dubnov Raz, Gal ^a,b   Pessach, Itai M ^a,b   Simon, Amos J ^a   Lev, Atar ^a   Somech, Raz ^a,b  

^a SHEBA MEDICAL CENTER   (Israel)

^b TEL AVIV UNIVERSITY   (Israel)

^c GEHA MENTAL HEALTH CENTER   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGE DISTRIBUTION; ARTICLE; B LYMPHOCYTE; BONE MARROW; CHILD; CHROMOSOME DELETION 22Q11; CHROMOSOME REARRANGEMENT; CONTROLLED STUDY; CORRELATION ANALYSIS; DNA MARKER; FALLOT TETRALOGY; FEMALE; HEART ATRIUM SEPTUM DEFECT; HEART SURGERY; HEART VENTRICLE SEPTUM DEFECT; HUMAN; KAPPA DELETING RECOMBINATION EXCISION CIRCLE; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RECURRENT INFECTION; T CELL RECEPTOR REARRANGEMENT EXCISION CIRCLE; T LYMPHOCYTE; THYMECTOMY; THYMUS; CASE CONTROL STUDY; CYTOLOGY; DIGEORGE SYNDROME; GENE REARRANGEMENT; GENETIC RECOMBINATION; GENETICS; IMMUNOLOGY; PATHOLOGY; YOUNG ADULT;

ADOLESCENT; ADULT; B-LYMPHOCYTES; BONE MARROW; CASE-CONTROL STUDIES; CHILD; DIGEORGE SYNDROME; FEMALE; GENE REARRANGEMENT, B-LYMPHOCYTE; GENE REARRANGEMENT, T-LYMPHOCYTE; HUMANS; MALE; RECOMBINATION, GENETIC; T-LYMPHOCYTES; THYMUS GLAND; YOUNG ADULT;

EID: 84924975971     PISSN: 00313998     EISSN: 15300447     Source Type: Journal    
DOI: 10.1038/pr.2015.14     Document Type: Article

References (35)

1. Burn J. Closing time for CATCH22. J Med Genet 1999; 36: 737-8
2. Kirkpatrick JA Jr, DiGeorge AM. Congenital absence of the thymus. Am J Roentgenol Radium Ther Nucl Med 1968; 103: 32-7
3. Driscoll DA, Spinner NB, Budarf ML, et al. Deletions and microdeletions of 22q11.2 in velo-cardio-facial syndrome. Am J Med Genet 1992; 44: 261-8
4. Motzkin B, Marion R, Goldberg R, Shprintzen R, Saenger P. Variable phenotypes in velocardiofacial syndrome with chromosomal deletion. J Pediatr 1993; 123: 406-10
5. Gennery AR. Immunological aspects of 22q11.2 deletion syndrome. Cell Mol Life Sci 2012; 69: 17-27
6. Piliero LM, Sanford AN, McDonald-McGinn DM, Zackai EH, Sullivan KE. T-cell homeostasis in humans with thymic hypoplasia due to chromosome 22q11.2 deletion syndrome. Blood 2004; 103: 1020-5
7. Junker AK, Driscoll DA. Humoral immunity in DiGeorge syndrome. J Pediatr 1995; 127: 231-7
8. McLean-Tooke A, Spickett GP, Gennery AR. Immunodeficiency and autoimmunity in 22q11.2 deletion syndrome. Scand J Immunol 2007; 66: 1-7
9. Patel K, Akhter J, Kobrynski L, et al. Immunoglobulin deficiencies: the B-lymphocyte side of DiGeorge Syndrome. J Pediatr 2012; 161: 950-3
10. Markert ML, Hummell DS, Rosenblatt HM, et al. Complete DiGeorge syndrome: persistence of profound immunodeficiency. J Pediatr 1998; 132: 15-21
11. Bensoussan D, Le Deist F, Latger-Cannard V, et al. T-cell immune constitution after peripheral blood mononuclear cell transplantation in complete DiGeorge syndrome. Br J Haematol 2002; 117: 899-906
12. Sediva A, Bartunkova J, Zachova R, et al. Early development of immunity in diGeorge syndrome. Med Sci Monit 2005; 11: CR182-7
13. Friedman MA, Miletta N, Roe C, et al. Cleft palate, retrognathia and congenital heart disease in velo-cardio-facial syndrome: a phenotype correlation study. Int J Pediatr Otorhinolaryngol 2011; 75: 1167-72
14. Halnon NJ, Cooper P, Chen DY, Boechat MI, Uittenbogaart CH. Immune dysregulation after cardiothoracic surgery and incidental thymectomy: maintenance of regulatory T cells despite impaired thymopoiesis. Clin Dev Immunol 2011; 2011: 915864
15. Kurobe H, Tominaga T, Sugano M, et al. Complete but not partial thymectomy in early infancy reduces T-cell-mediated immune response: threeyear tracing study after pediatric cardiac surgery. J Thorac Cardiovasc Surg 2013; 145: 656-62, 662.e1-2; discussion 662
16. Michaelovsky E, Frisch A, Carmel M, et al. Genotype-phenotype correlation in 22q11.2 deletion syndrome. BMC Med Genet 2012; 13: 122
17. Mensen A, Ochs C, Stroux A, et al. Utilization of TREC and KREC quantification for the monitoring of early T-And B-cell neogenesis in adult patients after allogeneic hematopoietic stem cell transplantation. J Transl Med 2013; 11: 188
18. Serana F, Airo P, Chiarini M, et al. Thymic and bone marrow output in patients with common variable immunodeficiency. J Clin Immunol 2011; 31: 540-9
19. Kwan A, Church JA, Cowan MJ, et al. Newborn screening for severe combined immunodeficiency and T-cell lymphopenia in California: results of the first 2 years. J Allergy Clin Immunol 2013; 132: 140-50
20. Routes JM, Grossman WJ, Verbsky J, et al. Statewide newborn screening for severe T-cell lymphopenia. JAMA 2009; 302: 2465-70
21. Guo T, McDonald-McGinn D, Blonska A, et al. Genotype and cardiovascular phenotype correlations with TBX1 in 1, 022 velo-cardio-facial/DiGeorge/22q11.2 deletion syndrome patients. Hum Mutat 2011; 32: 1278-89
22. Dion ML, Sekaly RP, Cheynier R. Estimating thymic function through quantification of T-cell receptor excision circles. Methods Mol Biol 2007; 380: 197-213
23. Douek DC, Vescio RA, Betts MR, et al. Assessment of thymic output in adults after haematopoietic stem-cell transplantation and prediction of T-cell reconstitution. Lancet 2000; 355: 1875-81
24. Serana F, Chiarini M, Zanotti C, et al. Use of V(D)J recombination excision circles to identify T-And B-cell defects and to monitor the treatment in primary and acquired immunodeficiencies. J Transl Med 2013; 11: 119
25. Chinen J, Rosenblatt HM, Smith EO, Shearer WT, Noroski LM. Long-Term assessment of T-cell populations in DiGeorge syndrome. J Allergy Clin Immunol 2003; 111: 573-9
26. Finocchi A, Di Cesare S, Romiti ML, et al. Humoral immune responses and CD27+ B cells in children with DiGeorge syndrome (22q11.2 deletion syndrome). Pediatr Allergy Immunol 2006; 17: 382-8
27. Waldmann H. Interactions between T and B cells: a review. J R Soc Med 1979; 72: 198-202
28. Kobrynski LJ, Sullivan KE. Velocardiofacial syndrome, DiGeorge syndrome: the chromosome 22q11.2 deletion syndromes. Lancet 2007; 370: 1443-52
29. Tomita-Mitchell A, Mahnke DK, Larson JM, et al. Multiplexed quantitative real-Time PCR to detect 22q11.2 deletion in patients with congenital heart disease. Physiol Genomics 2010; 42A: 52-60
30. Vogel BH, Bonagura V, Weinberg GA, et al. Newborn screening for SCID in New York State: experience from the first two years. J Clin Immunol 2014; 34: 289-303
31. Lingman Framme J, Borte S, von Dobeln U, Hammarstrom L, Oskarsdottir S. Retrospective analysis of TREC based newborn screening results and clinical phenotypes in infants with the 22q11 deletion syndrome. J Clin Immunol 2014; 34: 514-9
32. Gothelf D, Presburger G, Levy D, et al. Genetic, developmental, and physical factors associated with attention deficit hyperactivity disorder in patients with velocardiofacial syndrome. Am J Med Genet B Neuropsychiatr Genet 2004; 126B: 116-21
33. Gothelf D, Schneider M, Green T, et al. Risk factors and the evolution of psychosis in 22q11.2 deletion syndrome: a longitudinal 2-site study. J Am Acad Child Adolesc Psychiatry 2013; 52: 1192-1203.e3
34. Hazenberg MD, Verschuren MC, Hamann D, Miedema F, van Dongen JJ. T cell receptor excision circles as markers for recent thymic emigrants: basic aspects, technical approach, and guidelines for interpretation. J Mol Med (Berl) 2001; 79: 631-40
35. Lev A, Simon AJ, Broides A, et al. Thymic function in MHC class II-deficient patients. J Allergy Clin Immunol 2013; 131: 831-9